Diagnosis of the myeloproliferative disorders: Resolving phenotypic mimicry

Seminars in Hematology

Volumn 40, Issue 1 SUPPL. 1, 2003, Pages 1-5

  Spivak, Jerry L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; PROTEIN TYROSINE KINASE; THROMBOPOIETIN RECEPTOR;

CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; ERYTHROCYTOSIS; GENE OVEREXPRESSION; HEMATOCRIT; HUMAN; LABORATORY DIAGNOSIS; MEDICAL SOCIETY; MOLECULAR MIMICRY; MOLECULAR RECOGNITION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; PHENOTYPE; PLASMA VOLUME; POLYCYTHEMIA VERA; PRIORITY JOURNAL; THROMBOCYTOSIS;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA VERA; THROMBOCYTOSIS;

EID: 0037250958     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(03)70051-1     Document Type: Conference Paper

References (15)

1. Sattler M, Griffin JD: Mechanisms of transformation of the BRC/AML oncogene. Int J Hematol 73:278-291, 2000
2. Wasserman LR: The management of polycythemia vera. Br J Haematol 21:371-376, 1971
3. Pearson TC, Guthrie DL, Simpson J, et al: Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionucleotides of the International Council for Standardization in Haematology. Br J Haematol 89:748-756, 1995
4. Streiff MB, Smith B, Spivak JL: The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: A survey of American Society of Hematology members' practice patterns. Blood 99:1144-1149, 2002
5. Michiels JJ, Juvonen E: Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Polycythemia Vera Study Group. Semin Thromb Hemost 23:339-347, 1997
6. Moliterno AR, Hankins WD, Spivak JL: Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med 338:572-580, 1998
7. Moliterno AR, Spivak JL: Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood 94:2555-2561, 1999
8. Moliterno AR, Williams DM, Spivak JL: Enhanced in vitro viability of polycythemia vera CD34+ cells is associated with abnormal thrombopoietin receptor expression and aberrant signal transduction. Blood 98:469a, 2001 (suppl 1, abstr)
9. Al-Atrash G, Shetty S, Idell S, et al: IL-2-mediated upregulation of uPA and uPAR in natural killer cells. Biochem Biophys Res Commun 292:184-189, 2000
10. Temerinac S, Klippel S, Strunck E, et al: Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood 95:2569-2576, 2000
11. Klippel S, Strunck E, Temerinac S, et al: Quantification of PRV-1 expression, a molecular marker for the diagnosis of polycythemia vera. Blood 98:470a, 2001 (suppl 1, abstr)
12. Pahl HL: Towards a molecular understanding of polycythemia rubra vera. Eur J Biochem 267:3395-3401, 2000
13. Barosi G, Ambrosetti A, Finelli C, et al: The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia. Br J. Haematol 104:730-737, 1999
14. Barosi G, Viarengo G, Pecci A, et al: Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 90:3249-3255, 2001
15. Horikawa Y, Matsumura I, Hashimoto K, et al: Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 90:4031-4038, 1997